Effect of trans-Cinnamaldehyde on Adhesion and Other Virulence Factors of Methicillin-Resistant Staphylococcus aureus

Barbara Kot1, Kamila Wierzchowska1, Agata Grużewska2

  • 1Institute of Biological Sciences, Faculty of Exact and Natural Sciences, University of Siedlce, 14 Bolesława Prusa Str., 08-110 Siedlce, Poland.

Insights

Trans-cinnamaldehyde (TC) effectively reduces Methicillin-resistant Staphylococcus aureus (MRSA) virulence factors like adhesion and enzyme production. This natural compound shows promise as an alternative to antibiotics for MRSA infections.

Area of Science:

  • Microbiology
  • Natural Product Chemistry
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen causing difficult-to-treat infections.
  • MRSA virulence factors, including adhesion and enzymatic activities, contribute to its pathogenicity.
  • Novel therapeutic strategies are needed to combat rising antibiotic resistance.

Purpose of the Study:

  • To investigate the impact of trans-cinnamaldehyde (TC) on key virulence factors of MRSA.
  • To evaluate TC's efficacy in inhibiting MRSA adhesion to host proteins.
  • To assess TC's effect on MRSA protease, DNase, esterase production, and hemolytic activity.

Main Methods:

  • MRSA isolates were used to test the effects of TC.
  • TC's impact on bacterial adhesion to fibrinogen, elastin, laminin, and collagen was measured.
  • Enzyme production (protease, DNase, esterase) and hemolytic activity were assessed at sub-MIC concentrations of TC.

Main Results:

  • TC significantly reduced MRSA adhesion to host proteins at sub-inhibitory concentrations (½ MBIC).
  • TC markedly inhibited MRSA enzyme production and hemolytic activity at ½ MIC.
  • Observed inhibition percentages for adhesion ranged from 17.1% to 41.3% across different proteins and isolates.

Conclusions:

  • Trans-cinnamaldehyde (TC) effectively attenuates multiple MRSA virulence factors at sub-inhibitory concentrations.
  • TC presents a potential alternative or adjunct therapy for MRSA infections, reducing bacterial virulence.
  • Further research is needed to identify synergistic compounds to mitigate TC's cytotoxicity at higher concentrations.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
46
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
95